Spike, S1, RBD, SARS-CoV-2 plasmids
![](https://www.invivogen.com/sites/default/files/pictures/sars2-spike-coding-plasmids-invivogen.png)
InvivoGen offers genes encoding SARS-CoV-2 full-length Spike (S) or fragments (S1 and RBD), from the Wuhan-Hu-1 isolate (D614) in different plasmids. His- or Fc-tagged coding sequences available. Fully sequenced. Blasticidin-resistance.
![](https://www.medrxiv.org/content/medrxiv/early/2020/06/23/2020.06.22.20137695/F2.large.jpg)
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses
![](https://www.invivogen.com/sites/default/files/pictures/puno1fc-his-sars2-rbd-small-invivogen.png)
RBD tagged, SARS-CoV-2 plasmids
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00018-022-04246-w/MediaObjects/18_2022_4246_Fig1_HTML.png)
Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence
![](https://www.genetex.com/upload/media/MarketingMaterial/Newsletter/2022/BQ1BF7/landingPage_img_255x255_2.jpg)
SARS-CoV-2 (COVID-19) Antibodies and Reagents
![](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2020/10/Captured-3.jpg)
Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity
![](https://www.frontiersin.org/files/Articles/618615/fbioe-08-618615-HTML/image_m/fbioe-08-618615-g001.jpg)
Frontiers Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct
![](https://media.addgene.org/snapgene-media/v1.7.9-0-g88a3305/sequences/323637/5fbe10fe-5b26-4f2d-9d4e-5c07f09d395c/addgene-plasmid-164221-sequence-323637-map.png)
Addgene: RBD-Fc
![](https://www.biorxiv.org/content/biorxiv/early/2020/09/13/2020.09.10.286948/F5.large.jpg)
Real-time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles
![](https://www.science.org/cms/10.1126/sciimmunol.abc8413/asset/59b08c4f-297a-47ca-a323-96432b8f5d76/assets/graphic/abc8413-f1.jpeg)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00284-022-02866-w/MediaObjects/284_2022_2866_Fig1_HTML.png)
Oral Immunization of Mice with Cell Extracts from Recombinant Lactococcus lactis Expressing SARS-CoV-2 Spike Protein